Cancer clinical trials in the region Nouvelle-Aquitaine
195 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT05275478
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif)
Tango Therapeutics
Phase 2
Lymphoma
#NCT02875548
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
Targeted therapy
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Centre Henri Becquerel (Rouen ), Hôpital Claude Huriez (Lille) (and 3 more...)
Epizyme, Inc. (Ipsen)
Phase 2
Lung cancer
#NCT06393816
SCLC (Small Cell Lung Cancer)
Locally Advanced
Immunotherapy
Surgery
Immunotherapy
Radiotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Centre Léon Bérard
Phase 2
Lung cancer
#NCT06393816
SCLC (Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Centre Léon Bérard
Phase 2
Lung cancer
#NCT06162221
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
KRAS non G12C
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Hôpital Louis Pradel (Bron ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Nantes (Nantes) (and 1 more...)
Revolution Medicines, Inc.
Phase 2
Pancreas cancer
#NCT05275478
Adenocarcinoma
Other
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Tango Therapeutics
Phase 2
Pancreas cancer
#NCT04705818
Locally Advanced
Metastatic
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut Bergonié (Bordeaux)
Institut Bergonié
Phase 2
Pancreas cancer
#NCT04325425
Neuroendocrine tumor
Metastatic
Systemic Treatment-Naive
Chemotherapy
Targeted therapy
CHU Caen Normandie (Caen), Centre hospitalier universitaire François Mitterrand (Dijon), Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier de Saint-Malo (Saint-Malo) (and 2 more...)
CHU Dijon
Phase 2
Lung cancer
#NCT04956640
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux)
Eli Lilly et compagnie
Phase 2
Colon cancer
Rectal cancer
#NCT04956640
Locally Advanced
Metastatic
KRAS G12C
Chemotherapy
Institut Bergonié (Bordeaux), IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
Eli Lilly et compagnie